Health Ministry Cautions Malaysians Against Counterfeit Weight-Loss Injections

PUTRAJAYA — Malaysia's Ministry of Health has cautioned the public against purchasing or using so-called 'weight-loss pens' that contain Retatrutide, an unapproved pharmaceutical substance not cleared for distribution or use within the country.

The warning highlights growing concerns over the circulation of counterfeit and unregulated weight-loss products in the Malaysian market. These injectable medications, marketed as slimming solutions, pose significant health risks to consumers as they lack proper medical oversight and quality assurance.

Retatrutide, a compound typically associated with metabolic treatments, has not received approval from Malaysia's regulatory authorities for commercial sale or clinical use. The Ministry of Health emphasised that purchasing such products outside official pharmaceutical channels exposes consumers to unknown ingredients, incorrect dosages, and potentially harmful side effects.

The ministry urged the public to obtain weight-management treatments only through licensed healthcare providers and registered pharmacies. Individuals seeking weight-loss solutions should consult qualified medical professionals who can recommend safe, regulated alternatives tailored to their medical needs.

Authorities have reminded consumers that legitimate medications undergo rigorous testing and certification before approval. The public is encouraged to report suspicious weight-loss products or sellers to the relevant health authorities for investigation and enforcement action.